The appeal of decentralized clinical trials is easy to understand. When certain study activities can happen remotely, at home, or through local providers, participation can become more practical for people who may not live near a research site or have the time, money, or flexibility to travel often.
But decentralized doesn’t mean effortless. A participant may have fewer traditional site visits, but more pieces to manage between them: a telehealth appointment, a home health visit, a local lab draw, a study device, a stipend question, a reimbursement request, a change in travel plans. Each piece may have a clear owner on the back end. To the participant, it still needs to feel like one study.
Support can’t be an afterthought in decentralized and hybrid trials. When trial activity becomes more distributed, participants need clearer direction. Sites need fewer stray questions landing on already-stretched teams. Sponsors and CROs need a better view of where friction is happening before it turns into missed visits, unresolved payments, or avoidable dropout risk.
Decentralized trials can reduce burden. They can also move burden around. The difference often comes down to how well the support around the study is designed.
The FDA describes decentralized clinical trials as studies where some or all trial-related activities occur away from traditional clinical trial sites. That can include telehealth visits, in-home visits from trial personnel, or visits with local healthcare providers who are closer to the participant.
Those options can make a real difference, especially for participants who live far from a site, have limited transportation, or cannot easily step away from work, caregiving, or daily responsibilities.
But moving a trial activity closer to the participant doesn't make the activity manage itself.
A telehealth visit still needs scheduling, reminders, technology instructions, privacy considerations, and a clear plan for what happens if the participant cannot connect. An in-home visit still depends on timing, staffing, participant comfort, documentation, and follow-up. A local lab or provider visit may reduce travel distance, but someone still has to make sure the participant knows where to go, what to bring, what will be covered, and who to call if the appointment changes.
For Sponsors and CROs, these may be separate operational pieces. For the participant, they are all part of the same study.
A decentralized model can reduce certain burdens while creating new handoffs between the site, Sponsor, vendor partners, home health teams, local providers, and the participant. Without clear support, those handoffs can become the participant’s problem to solve.
In a traditional site-based model, participants may know where to go when they have a question. The site is the center of the experience, even when other vendors or services are working behind the scenes. In a decentralized or hybrid trial, that center can appear less obvious.
A participant may interact with the site for certain visits, a home health provider for an in-home assessment, a local lab for testing, a travel vendor for occasional site visits, a payment vendor for reimbursements, and a study app for reminders or data entry. Each interaction makes sense within the study plan. But for the person trying to participate, the experience can start to feel scattered.
Participants might not know whether to call the site, the app help desk, the travel team, or the person who scheduled the home visit. They may not realize which expenses are covered, how to submit receipts, or whether a local appointment counts toward a visit payment. They might understand one instruction clearly, then get stuck on the next step because it came from a different system or contact.
This kind of friction often happens between formal study milestones. You see it in quick questions, missed messages, delayed reimbursements, rescheduled appointments, and extra calls to site staff.
For decentralized trials to feel workable, the participant experience has still got to be coherent. People need clear instructions, consistent communication, and support that understands how the pieces fit together. Otherwise, a more flexible trial can start to feel like more work.
Even in a traditional trial, coordinators often become the person participants turn to first. They answer visit questions, chase paperwork, explain next steps, manage schedule changes, and absorb problems that technically belong somewhere else. In a decentralized or hybrid trial, that pull can get stronger if support responsibilities are not clearly defined.
A participant with a question about a home health visit calls the site. Or a missed reimbursement lands on the coordinator’s to-do list. A local lab issue turns into a site follow-up. A travel change, app problem, receipt question, or appointment mix-up can all find their way back to the same already-busy team.
When site staff spend more time sorting out vendor handoffs and participant logistics, they have less time for the clinical and administrative work only they can do. The decentralized model may have moved certain activities away from the site, but the support burden still finds the site unless someone else is accountable for catching it.
Decentralized trials should reduce avoidable burden for sites instead of spawning a new stream of “Who handles this?” questions.
That takes a support model with clear ownership. Participants need to know where to go for help. Sites should know which issues they can hand off with confidence. Sponsors and CROs want fewer blind spots between participant activity, vendor follow-up, and site workload.
Hybrid participation can change what a participant needs to do, where they need to go, and what support they need along the way. That also impacts the way payments and logistics have to be managed.
A participant may have a telehealth visit one week, a local lab visit the next, an in-home assessment after that, and an occasional trip to the main site when the protocol requires it. Each activity may come with different instructions, different costs, and different reimbursement needs. Mileage may apply for one visit, parking for another. A stipend may be tied to a completed assessment, a procedure, a visit window, or a receipt that has to be reviewed before payment can be issued.
Flat, visit-based payment models can start to feel too blunt for that kind of participation. They may work for some studies, but they do not always reflect what participants are actually doing across remote, local, home-based, and site-based activities.
Logistics can layer up, too. Fewer required site visits may mean less routine travel, but the travel that remains may be more specific and higher stakes. A participant may still need flights, lodging, ground transportation, meal support, or help adjusting plans when a visit moves. Local options can reduce distance, but they still require clear instructions, coverage details, and a support path when something changes.
These details are easy to brush off as admin. For participants, they are part of the experience. A missed reimbursement, unclear travel instruction, or unresolved payment question can make a flexible trial feel harder than expected.
Decentralized and hybrid trials need payment and logistics support that can adjust to the way participation actually happens. That means clear reimbursement rules, reliable follow-up, flexible payment options, and enough visibility for study teams to understand what has been completed, what is pending, and where participants may need help.
Learn more about Scout’s clinical trial payment and reimbursement support.
Decentralized and hybrid trials ask participants to complete study activities across more settings. That can make participation more flexible, but it also gives participants more to keep track of.
Support’s got to follow the participant through the full experience. Not just the site visit, or the reimbursement, or the travel itinerary. The full sequence of instructions, appointments, questions, payments, changes, and follow-up that determines whether participation feels manageable.
The right support shapes outcomes. Scout helps study teams keep those pieces from drifting apart.
A participant should be able to understand what comes next, which costs are covered, how to get help when travel changes, and where to ask a payment question without chasing multiple contacts. A site team should be able to hand off logistics and reimbursement questions without worrying that the participant will get lost. A Sponsor or CRO should be able to see where support issues are building before they become missed visits, unresolved payments, or retention risk.
The study may involve more locations, vendors, visit types, and payment triggers, but the person participating shouldn’t have to assemble the experience on their own. Scout’s role is to help keep that experience clear, supported, and easier to complete.
Decentralized clinical trials can make participation feel more manageable, but only when the support around the protocol matches the way people actually move through a study.
That means planning for the schedule changes, payment questions, travel needs, local logistics, missed messages, and moments when a participant needs a clear answer from someone who gets the full experience.
When the support works, participants feel the difference in ordinary ways: the next step is clear, the reimbursement question has a place to go, the travel change does not derail the visit, and the study feels possible to continue.